Clinical Trials Finder
Independent ClinicalTrials.gov directory
ClinicalTrials.gov record
Recruiting Phase 1Phase 2 Interventional

Testing the Combination of Two Approved Drugs and One Experimental Drug in Patients With Relapsed or Refractory Multiple Myeloma

ClinicalTrials.gov ID: NCT06232044

Public ClinicalTrials.gov record NCT06232044. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced Apr 29, 2026, 8:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase I/II Study of the Safety, Tolerability and Efficacy of Belantamab Mafodotin (GSK2857916) in Combination With Iberdomide (CC-220)/Dexamethasone Versus Belantamab Mafodotin (GSK2857916)/Dexamethasone in Relapsed Refractory Multiple Myeloma

Study identification

NCT ID
NCT06232044
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Alliance for Clinical Trials in Oncology
Other
Enrollment
88 participants

Conditions and interventions

Interventions

  • Belantamab Mafodotin Biological
  • Biospecimen Collection Procedure
  • Bone Marrow Aspiration Procedure
  • Bone Marrow Biopsy Procedure
  • Computed Tomography Procedure
  • Dexamethasone Drug
  • Echocardiography Procedure
  • Iberdomide Drug
  • Magnetic Resonance Imaging Procedure
  • Positron Emission Tomography Procedure

Biological · Procedure · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 22, 2025
Primary completion
Apr 30, 2028
Completion
Jul 31, 2030
Last update posted
Mar 24, 2026

2025 – 2030

United States locations

U.S. sites
40
U.S. states
10
U.S. cities
30
Facility City State ZIP Site status
Mary Greeley Medical Center Ames Iowa 50010 Recruiting
McFarland Clinic - Ames Ames Iowa 50010 Recruiting
McFarland Clinic - Boone Boone Iowa 50036 Suspended
McFarland Clinic - Trinity Cancer Center Fort Dodge Iowa 50501 Recruiting
McFarland Clinic - Jefferson Jefferson Iowa 50129 Suspended
McFarland Clinic - Marshalltown Marshalltown Iowa 50158 Recruiting
Tufts Medical Center Boston Massachusetts 02111 Recruiting
Dana-Farber Cancer Institute Boston Massachusetts 02215 Recruiting
Coborn Cancer Center at Saint Cloud Hospital Saint Cloud Minnesota 56303 Recruiting
Memorial Sloan Kettering Monmouth Middletown New Jersey 07748 Recruiting
Memorial Sloan Kettering Bergen Montvale New Jersey 07645 Recruiting
Memorial Sloan Kettering Commack Commack New York 11725 Recruiting
Memorial Sloan Kettering Westchester Harrison New York 10604 Recruiting
Memorial Sloan Kettering Cancer Center New York New York 10065 Recruiting
OhioHealth O'Bleness Hospital Athens Ohio 45701 Recruiting
Columbus Oncology and Hematology Associates Inc Columbus Ohio 43214 Recruiting
Riverside Methodist Hospital Columbus Ohio 43214 Recruiting
Grant Medical Center Columbus Ohio 43215 Recruiting
Doctors Hospital Columbus Ohio 43228 Recruiting
Delaware Health Center-Grady Cancer Center Delaware Ohio 43015 Recruiting
Grady Memorial Hospital Delaware Ohio 43015 Recruiting
Columbus Oncology and Hematology Associates Dublin Ohio 43016 Recruiting
Dublin Methodist Hospital Dublin Ohio 43016 Recruiting
OhioHealth Mansfield Hospital Mansfield Ohio 44903 Recruiting
OhioHealth Marion General Hospital Marion Ohio 43302 Recruiting
OhioHealth Pickerington Methodist Hospital Pickerington Ohio 43147 Recruiting
OhioHealth Westerville Medical Campus/Westerville Cancer Center Westerville Ohio 43082 Recruiting
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104 Recruiting
Vanderbilt University/Ingram Cancer Center Nashville Tennessee 37232 Recruiting
Huntsman Cancer Institute/University of Utah Salt Lake City Utah 84112 Recruiting
Saint Vincent Hospital Cancer Center Green Bay Green Bay Wisconsin 54301 Recruiting
Saint Vincent Hospital Cancer Center at Saint Mary's Green Bay Wisconsin 54303 Recruiting
Medical College of Wisconsin Milwaukee Wisconsin 53226 Recruiting
ProHealth D N Greenwald Center Mukwonago Wisconsin 53149 Recruiting
ProHealth Oconomowoc Memorial Hospital Oconomowoc Wisconsin 53066 Recruiting
Saint Vincent Hospital Cancer Center at Sheboygan Sheboygan Wisconsin 53081 Recruiting
Sheboygan Physicians Group Sheboygan Wisconsin 53081 Recruiting
Saint Vincent Hospital Cancer Center at Sturgeon Bay Sturgeon Bay Wisconsin 54235-1495 Recruiting
ProHealth Waukesha Memorial Hospital Waukesha Wisconsin 53188 Recruiting
UW Cancer Center at ProHealth Care Waukesha Wisconsin 53188 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06232044, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 24, 2026 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06232044 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →